85 results
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
13 Nov 23
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
9:00am
as a treatment option in patients diagnosed with DCIS. The RECAST DCIS study, which is organized by Quantum Leap Healthcare Collaborative, is aimed
8-K
EX-99.1
pg9 z2r9m861ywjz
15 May 23
Atossa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
9:10am
424B2
z2lqaz
4 Feb 21
Prospectus for primary offering
4:16pm
424B3
uip sh7jhr8jfzhg
8 Jan 21
Prospectus supplement
9:15am
424B5
kqjy577soaxe74u8t
21 Dec 20
Prospectus supplement for primary offering
9:16am
424B3
f9dgrh3r7n5 yq
11 Dec 20
Prospectus supplement
7:28am